Huang, Anfei
Peng, Di
Guo, Huanhuan
Ben, Yinyin
Zuo, Xiangyang
Wu, Fei
Yang, Xiaoli
Teng, Fei
Li, Zhen
Qian, Xueming
Qin, F. Xiao-Feng
Article History
Received: 22 June 2016
Accepted: 13 January 2017
First Online: 16 February 2017
Competing interests
: This study has competing financial interests. A patent has been filed for the utilization of this tumor model for pre-clinical evaluation of anti-human PD-L1 antibodies. Cell line deposit information: China Center for Type Culture Collection (CCTCC), NO: C201697.